Skip to Main Content

Annalies Denoble, MD, MSc

Assistant Professor of Obstetrics, Gynecology and Reproductive Sciences

Contact Information

Annalies Denoble, MD, MSc

Mailing Address

  • Obstetrics, Gynecology & Reproductive Sciences

    333 Cedar Street

    New Haven, CT 06510

    United States

Research Summary

Dr. Denoble's clinical research focuses on learning more about complications that can arise from heart disease in pregnancy and how better to address and prevent these complications.

Extensive Research Description

As an Assistant Professor in Obstetrics & Gynecology and a board-eligible maternal-fetal medicine specialist, Dr. Denoble's goal is to improve our understanding of cardiovascular diseases in pregnancy and the postpartum period through innovative, patient-relevant research. Cardiac disease is the leading cause of maternal mortality in the United States, but evidence-based strategies for diagnosing, treating, and preventing cardiovascular disease in pregnancy remain limited. Her clinical research involves improving the accuracy of risk prediction models for both adverse cardiac events in pregnancy and severe maternal morbidity and mortality. Ultimately, her goal is to develop strategies that can be employed in the pre-conception and early pregnancy period to better mitigate the risks of pre-existing cardiac disease in pregnancy. Her prior research focused on differences in clinical biomarkers of heart failure between pregnant women with and without obesity, given that obesity is a risk factor for cardiac disease and may complicate the diagnosis of cardiovascular complications in pregnancy. Her background in clinical research through a Master of Science in Clinical Research provides a solid foundation upon which to build her investigation.

She also conducts epidemiologic and clinical research in preeclampsia and hypertension in pregnancy, vaccine safety in pregnancy, and infections in pregnancy.

Coauthors

Research Interests

Pregnancy Complications, Cardiovascular

Selected Publications

  • Delayed gestational diabetes diagnosis: maternal characteristics, reasons for delay, and delivery outcomesDing J, Lundsberg L, Culhane J, Partridge C, Denoble A, Son M. Delayed gestational diabetes diagnosis: maternal characteristics, reasons for delay, and delivery outcomes American Journal Of Obstetrics And Gynecology 2023, 228: s149-s150. DOI: 10.1016/j.ajog.2022.11.294.
  • Maternal and pregnancy outcomes following heart transplantation in the United StatesCraig A, Campbell A, Snow S, Denoble A, Agarwal R, Ward C, Federspiel J. Maternal and pregnancy outcomes following heart transplantation in the United States American Journal Of Obstetrics And Gynecology 2023, 228: s427-s428. DOI: 10.1016/j.ajog.2022.11.742.
  • Impact of Pre-Existing Ischemic Heart Disease on Severe Maternal Morbidity and Mortality During Delivery HospitalizationsDenoble A, Goldstein S, Wein L, Grotegut C, Federspiel J. Impact of Pre-Existing Ischemic Heart Disease on Severe Maternal Morbidity and Mortality During Delivery Hospitalizations JACC Advances 2022, 1: 100157. DOI: 10.1016/j.jacadv.2022.100157.
  • Maternal Anemia and the Severity of Urinary PathologyLuke S, Sachdeva S, Ohamadike O, Denoble A, Heine R, Dotters-Katz S. Maternal Anemia and the Severity of Urinary Pathology American Journal Of Obstetrics And Gynecology 2022, 226: 315. DOI: 10.1016/j.ajog.2021.11.1322.
  • Impact of Maternal BMI on Urinary Pathology Severity in PregnancyLuke S, Krischak M, Mitchell C, Denoble A, Ellett T, Heine R, Dotters-Katz S. Impact of Maternal BMI on Urinary Pathology Severity in Pregnancy American Journal Of Obstetrics And Gynecology 2022, 226: s297. DOI: 10.1016/j.ajog.2021.11.501.
  • Impact of chronic ischemic heart disease on severe maternal morbidity during delivery hospitalizationsDenoble A, Goldstein S, Grotegut C, Federspiel J. Impact of chronic ischemic heart disease on severe maternal morbidity during delivery hospitalizations American Journal Of Obstetrics And Gynecology 2022, 226: s77. DOI: 10.1016/j.ajog.2021.11.146.
  • Impact of mechanical versus bioprosthetic heart valve on severe maternal morbidity during delivery hospitalizationsDenoble A, Federspiel J, Goldstein S, Grotegut C. Impact of mechanical versus bioprosthetic heart valve on severe maternal morbidity during delivery hospitalizations American Journal Of Obstetrics And Gynecology 2022, 226: s469-s470. DOI: 10.1016/j.ajog.2021.11.778.
  • 532 Comparison of N-terminal pro-brain natriuretic peptide levels in healthy obese and non-obese pregnant womenDeNoble A, Moyett J, Goldstein S, Ward C, James A, Grotegut C. 532 Comparison of N-terminal pro-brain natriuretic peptide levels in healthy obese and non-obese pregnant women American Journal Of Obstetrics And Gynecology 2021, 224: s337. DOI: 10.1016/j.ajog.2020.12.553.
  • 734 Severe maternal morbidity by modified WHO classification in women with cardiac disease in pregnancyDeNoble A, Federspiel J, Wein L, Goldstein S, Grotegut C. 734 Severe maternal morbidity by modified WHO classification in women with cardiac disease in pregnancy American Journal Of Obstetrics And Gynecology 2021, 224: s460-s461. DOI: 10.1016/j.ajog.2020.12.757.
  • The impact of anemia on infectious and obstetric outcomes of women with pyelonephritisCunningham H, Federspiel J, Wein L, DeNoble A, Heine R, Dotters-Katz S. The impact of anemia on infectious and obstetric outcomes of women with pyelonephritis American Journal Of Obstetrics And Gynecology 2020, 223: 976. DOI: 10.1016/j.ajog.2020.08.152.
  • 1069: Bad bugs: antibiotic-resistant lower urinary tract infections and risk of pyelonephritis in pregnancyDeNoble A, Krischak M, Rosett H, Sachdeva S, Weaver K, Heine P, Dotters-Katz S. 1069: Bad bugs: antibiotic-resistant lower urinary tract infections and risk of pyelonephritis in pregnancy American Journal Of Obstetrics And Gynecology 2020, 222: s660. DOI: 10.1016/j.ajog.2019.11.1082.
  • 1205: Pregnancy outcomes among class 3 obese women with normal and pre-diabetic early hemoglobin A1CMitchell C, Ellett T, Dillon J, Siegel A, DeNoble A, Dotters-Katz S. 1205: Pregnancy outcomes among class 3 obese women with normal and pre-diabetic early hemoglobin A1C American Journal Of Obstetrics And Gynecology 2020, 222: s740-s741. DOI: 10.1016/j.ajog.2019.11.1217.
  • 268: Beyond expert opinion: A comparison of antibiotic regimens for infectious urinary tract pathology in pregnancyKrischak M, Rosett H, Sachdeva S, Weaver K, Heine P, DeNoble A, Dotters-Katz S. 268: Beyond expert opinion: A comparison of antibiotic regimens for infectious urinary tract pathology in pregnancy American Journal Of Obstetrics And Gynecology 2020, 222: s183. DOI: 10.1016/j.ajog.2019.11.284.
  • 470: Lower urinary pathogens: Do more virulent bacteria increase the risk of pyelonephritis?Rosett H, Krischak M, Sachdeva S, Weaver K, Heine P, DeNoble A, Dotters-Katz S. 470: Lower urinary pathogens: Do more virulent bacteria increase the risk of pyelonephritis? American Journal Of Obstetrics And Gynecology 2020, 222: s308. DOI: 10.1016/j.ajog.2019.11.486.
  • 490: GBS Urinary Tract Infections: Is the risk of pyelonephritis as high as with E. Coli?Sachdeva S, Rosett H, Krischak M, Weaver K, Heine P, DeNoble A, Dotters-Katz S. 490: GBS Urinary Tract Infections: Is the risk of pyelonephritis as high as with E. Coli? American Journal Of Obstetrics And Gynecology 2020, 222: s320-s321. DOI: 10.1016/j.ajog.2019.11.506.
  • Chorioamnionitis versus intraamniotic infection among preterm deliveries: is postpartum infectious morbidity different?DeNoble A, Mitchell C, Hughes B, Dotters-Katz S. Chorioamnionitis versus intraamniotic infection among preterm deliveries: is postpartum infectious morbidity different? American Journal Of Obstetrics And Gynecology 2019, 221: 666-667. DOI: 10.1016/j.ajog.2019.10.073.
  • Spiking in the Second Stage: What are the Neonatal Implications? [19D]Daifotis H, Smith M, Denoble A, Dotters-Katz S. Spiking in the Second Stage: What are the Neonatal Implications? [19D] Obstetrics And Gynecology 2019, 133: 47s-46s. DOI: 10.1097/01.aog.0000558975.44644.1a.
  • Using the New Definition of Intraamniotic Infection: Is There Morbidity in the Women Left Out? [27D]Smith M, Daifotis H, Denoble A, Dotters-Katz S. Using the New Definition of Intraamniotic Infection: Is There Morbidity in the Women Left Out? [27D] Obstetrics And Gynecology 2019, 133: 50s-48s. DOI: 10.1097/01.aog.0000558983.61677.1d.
  • Spiking in the Second Stage: The Significance of Isolated Maternal Fever During Labor [16A]Smith M, Daifotis H, Denoble A, Dotters-Katz S. Spiking in the Second Stage: The Significance of Isolated Maternal Fever During Labor [16A] Obstetrics And Gynecology 2019, 133: 14s-14s. DOI: 10.1097/01.aog.0000559363.72958.65.
  • Management of Intraamniotic Infection After Spontaneous Vaginal Delivery: Is Nothing Really Enough? [24C]Daifotis H, Smith M, Denoble A, Dotters-Katz S. Management of Intraamniotic Infection After Spontaneous Vaginal Delivery: Is Nothing Really Enough? [24C] Obstetrics And Gynecology 2019, 133: 37s-37s. DOI: 10.1097/01.aog.0000559445.77903.c7.
  • Chorioamnionitis and infectious complications after vaginal deliveryDenoble A, Heine R, Dotters-Katz S. Chorioamnionitis and infectious complications after vaginal delivery American Journal Of Obstetrics And Gynecology 2018, 219: 648. DOI: 10.1016/j.ajog.2018.10.046.
  • 955: Beyond the window: Determining a geographical target for interventions to decrease late initiation of prenatal care in 17-P eligible pregnant womenWheeler S, DeNoble A, Swamy G, Weaver K, Wynn C, Lantos P. 955: Beyond the window: Determining a geographical target for interventions to decrease late initiation of prenatal care in 17-P eligible pregnant women American Journal Of Obstetrics And Gynecology 2018, 218: s565-s566. DOI: 10.1016/j.ajog.2017.11.442.
  • Cost analysis of negative pressure wound therapy in morbidly obese women at the time of cesareanDeNoble A, Hughes B, Villers M. Cost analysis of negative pressure wound therapy in morbidly obese women at the time of cesarean American Journal Of Obstetrics And Gynecology 2017, 217: 723. DOI: 10.1016/j.ajog.2017.08.054.
  • Chronic disease and preventive reproductive health servicesDeNoble A, Hall K, Zochowski M, Dalton V. Chronic disease and preventive reproductive health services Contraception 2013, 88: 469-470. DOI: 10.1016/j.contraception.2013.05.148.